WRN and cancer: Moreover, several other compounds targeting proteins involved in DNA repair mechanisms have already shown promising results as potential new anti-cancer drugs in pre-clinical studies, such as BLM [66], WRN [67], RAD52 [68], or MRE11 [69] inhibitors.